Find the Perfect Plan for Your Investment Journey
D
Latest price
52 Week Range
€88.96 - €112.35
Next Earnings Date
May 08 2025
Next Earnings Date
May 08 2025
Latest price
Market Cap | €5.36B |
EV | €6.00B |
Shares Outstanding | 53.89M |
Beta | 0.40 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | €109.75 |
P/E 2025E | 22.42x |
P/Revenue 2025E | 4.19x |
Revenue | -1.40% |
EPS | -12.20% |
Operating Cash Flow | -3.60% |
Free Cash Flow | -7.40% |
Revenue | 8.10% |
EPS | 10.80% |
Operating Cash Flow | 5.80% |
Free Cash Flow | 10.10% |
Gross Margin 2025E | 66.50% |
Net Profit Margin 2025E | 17.21% |
ROE 2025E | 12.93% |
ROCE 2024 | 11.27% |
DPS 2025E | €1.24 |
Payout Ratio 2025E | 28.25% |
Div. Yield 2025E | 1.25% |
DPS Last 3Y CAGR | 4.60% |
Price
%
1M
3M
6M
1Y
3Y
5Y
D
DiaSorin S.p.A.
DIA
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Rosa, Carlo
Employees
3,279
Website
diasoringroup.com/enIPO Date
2007-07-19
Headquarters
Via Crescentino, Saluggia, Vercelli, 13040, Italy
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved